BioSpace News Archive

Photo of Boston, Massachusetts, at the Boston Harbor and Financial District with a mix of contemporary and historic architecture.

Job Trends

Looking for a biopharma job in Massachusetts? Check out the BioSpace list of nine companies hiring life sciences professionals like you.

August 21, 2025

·

1 min read

·

Chantal Dresner

Pictured: CDC signage at its headquarters in Georg

Government

Hundreds of HHS Staffers Accuse RFK Jr. of ‘Sowing Public Mistrust’ Against CDC After Shooting at HQ

In an open letter, Health and Human Services employees asked the Secretary to stop and disavow the spread of health misinformation, particularly about vaccines, infectious diseases and federal health agencies.

August 21, 2025

·

2 min read

·

Tristan Manalac

Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration

Regulatory

Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4

The delays, first revealed in Regeneron’s Q2 report, were chalked up to manufacturing issues at Novo Nordisk-owned plants.

August 21, 2025

·

2 min read

·

Tristan Manalac

Johnson & Johnson's business center in Switzerland

Manufacturing

J&J Adds $2B to US Manufacturing Commitment Amid Trump’s Protracted Tariff Threats

President Donald Trump first threatened pharma tariffs in February and recently said they were imminent. Johnson & Johnson’s new investment adds to a $55 billion pledge made by the company in March.

August 21, 2025

·

2 min read

·

Tristan Manalac

IN PARTNERSHIP WITH CRESSET

Why AI Won’t Save the 90% of Clinical Trials That Still Fail

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s potential to reduce preclinical costs with Mutlu Dogruel, VP of AI and Mark Mackey, CSO of Cresset.

August 21, 2025

·

1 min read

·

Lori Ellis

The white plane flies against the blue sky, leaving a white trail. Vector illustration

Regulatory

Stealth’s Flight Path Returns to FDA for Rejected Barth Drug

Stealth BioTherapeutics originally submitted elamipretide for approval in January 2024, only to receive a rejection in May of this year. In addition to accepting the biotech’s resubmission, the FDA has promised to take action on the candidate by Sept. 26.

August 21, 2025

·

1 min read

·

Annalee Armstrong

Photo showing Seattle downtown skyline and Mt. Rainier, Washington

Business

Washington’s Life Sciences Scene Moves Beyond Research Roots

Washington has had notable life sciences job growth over the past 10 years, according to a Life Science Washington report. The association’s CEO and a biopharma CEO discuss what makes the state stand out, including its talent pool, AI leadership and entrepreneurship support.

August 21, 2025

·

5 min read

·

Angela Gabriel

Press Releases

New England Journal of Medicine (NEJM) to Publish Results From Savara’s Pivotal Phase 3 IMPALA-2 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

August 21, 2025

·

7 min read

Press Releases

Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth